KLF4 and non-small cell lung carcinoma: It is worth noting that in the non-small cell lung cancer (NSCLC) mouse model, deguelin was found to inhibit the EMT process by promoting the expression of PTEN and KLF4, which further weakened the invasion and migration ability of NSCLC cells (Lu et al., 2022).